Elin Heldbo Reines

Lundbeck (Denmark) — Denmark

Medicine · Health Sciences

16h-index1.8kcitations38works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Treatment of Major Depression(29), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(17), Mental Health Research Topics(17), Tryptophan and brain disorders(9), Schizophrenia research and treatment(2)

Publications38 total

Vortioxetine in treatment of depression with somatic comorbidities in routine practice: sub-group analysis of the RELIEVE study
Journal of Affective Disorders·2025Open Access
Time to efficacious steady state plasma concentrations with slow titration of Vortioxetine drops versus oral tablets: a Pharmacokinetic model
Annals of General Psychiatry·2025Open Access
Patient Response Trajectories in Major Depressive Disorder
Psychopharmacology Bulletin·2025· 5 citedOpen Access
Effectiveness and Tolerability of Vortioxetine Oral Drops Versus Oral Tablets in Major Depressive Disorder: An Analysis of a Real-World Cohort Study in Switzerland
CNS Drugs·2025· 2 citedOpen Access
Time to steady state with slow titration of vortioxetine drops versus oral tablets: a pharmacokinetic model
2025Open Access
Functional improvement as a treatment goal in major depressive disorder: a narrative review of the evidence for vortioxetine
Current Medical Research and Opinion·2025
Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases
Current Medical Research and Opinion·2025· 2 cited
Vortioxetine in the Treatment of Major Depressive Disorder Among Working Patients in Routine Clinical Practice: An Analysis of a Post-Marketing Surveillance Study in South Korea
Neuropsychiatric Disease and Treatment·2024· 4 citedOpen Access
Minimal clinically important change in the MADRS anhedonia factor score: A pooled analysis of open-label studies with vortioxetine in patients with major depressive disorder
Journal of Affective Disorders·2024· 9 citedOpen Access
Goal setting and goal attainment in patients with major depressive disorder: a narrative review on shared decision making in clinical practice
Current Medical Research and Opinion·2024· 5 citedOpen Access
Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies
Current Medical Research and Opinion·2023· 17 citedOpen Access
Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
Frontiers in Psychiatry·2023· 8 citedOpen Access
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
Neuropsychiatric Disease and Treatment·2022· 19 citedOpen Access
Efficacy and safety of vortioxetine in treatment of patients with major depressive disorder and common co-morbid physical illness
Journal of Affective Disorders·2022· 24 citedOpen Access
P.0713 Effectiveness and safety of vortioxetine in real-world clinical practice in China: results from the prospective RELIEVE China study
European Neuropsychopharmacology·2021
Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
Alcohol and Alcoholism·2021· 7 citedOpen Access
Management of Depression in Adolescents in Japan
Journal of Child and Adolescent Psychopharmacology·2019· 11 cited
Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials
CNS Spectrums·2019· 14 citedOpen Access
Efficacy of escitalopram in the treatment of social anxiety disorder: A meta-analysis versus placebo
European Neuropsychopharmacology·2016· 37 citedOpen Access
The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies
Journal of Psychopharmacology·2016· 182 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

David S. Baldwin(7), Henrik Loft(6), Simon Nitschky Schmidt(4), Hongye Ren(4), Connie Sánchez(3), Stuart Montgomery(3), Ulla Lepola(3), Klaus Groes Larsen(3), Oscar Necking(3), Lene Hammer-Helmich(3), Daniel Oudin Åström(3), Christina Guiton(2), Ioana Florea(2), George G. Nomikos(2), Mariusz Papp(2), Henning Friis Andersen(2), Koen Demyttenaere(2), Michael E. Thase(2), Sidney H. Kennedy(2), Nicolas Despiégel(2)